Pfizer Inc. offered a rosy outlook for the year, outlining the benefits from the new U.S. tax law and casting the Amazon.com Inc.-led partnership to lower health-care costs as positive for the drug industry.
from WSJ.com: US Business http://ift.tt/2rRGOvI
via IFTTT
No comments:
Post a Comment